118 related articles for article (PubMed ID: 7608552)
21. The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells.
Haug M; Dannecker L; Schepp CP; Kwok WW; Wernet D; Buckner JH; Kalbacher H; Dannecker GE; Holzer U
Eur J Immunol; 2005 Nov; 35(11):3163-72. PubMed ID: 16245362
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors.
Bonnotte B; Favre N; Moutet M; Fromentin A; Solary E; Martin M; Martin F
J Immunol; 1998 Aug; 161(3):1433-8. PubMed ID: 9686608
[TBL] [Abstract][Full Text] [Related]
23. Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.
MacKenzie WM; Hoskin DW; Blay J
Exp Cell Res; 2002 May; 276(1):90-100. PubMed ID: 11978011
[TBL] [Abstract][Full Text] [Related]
24. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Cho JA; Lee YS; Kim SH; Ko JK; Kim CW
Cancer Lett; 2009 Mar; 275(2):256-65. PubMed ID: 19036499
[TBL] [Abstract][Full Text] [Related]
25. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
Castelli C; Ciupitu AM; Rini F; Rivoltini L; Mazzocchi A; Kiessling R; Parmiani G
Cancer Res; 2001 Jan; 61(1):222-7. PubMed ID: 11196165
[TBL] [Abstract][Full Text] [Related]
26. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation.
Yang WL; Nair DG; Makizumi R; Gallos G; Ye X; Sharma RR; Ravikumar TS
Ann Surg Oncol; 2004 Apr; 11(4):399-406. PubMed ID: 15070600
[TBL] [Abstract][Full Text] [Related]
27. H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells.
Labarrière N; Piau JP; Otry C; Denis M; Lustenberger P; Meflah K; Le Pendu J
Cancer Res; 1994 Dec; 54(23):6275-81. PubMed ID: 7525057
[TBL] [Abstract][Full Text] [Related]
28. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.
Todryk S; Melcher AA; Hardwick N; Linardakis E; Bateman A; Colombo MP; Stoppacciaro A; Vile RG
J Immunol; 1999 Aug; 163(3):1398-408. PubMed ID: 10415040
[TBL] [Abstract][Full Text] [Related]
29. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
[TBL] [Abstract][Full Text] [Related]
30. The study on the expression of membrane HSP70 protein in H22 cell and its immunoprotective mechanism against carcinoma.
Wu WZ; Liu KD; Xie Q; Wu HS
J Exp Clin Cancer Res; 1999 Dec; 18(4):543-8. PubMed ID: 10746982
[TBL] [Abstract][Full Text] [Related]
31. Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma.
Caignard A; Pelletier H; Martin F
Int J Cancer; 1988 Dec; 42(6):883-6. PubMed ID: 3263952
[TBL] [Abstract][Full Text] [Related]
32. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
Gri G; Chiodoni C; Gallo E; Stoppacciaro A; Liew FY; Colombo MP
Cancer Res; 2002 Aug; 62(15):4390-7. PubMed ID: 12154045
[TBL] [Abstract][Full Text] [Related]
34. Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat.
Shimizu T; Martin MS; Pelletier H; Lagadec P; Martin F
Immunobiology; 1989 Feb; 178(4-5):401-15. PubMed ID: 2785485
[TBL] [Abstract][Full Text] [Related]
35. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
36. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
Radons J; Multhoff G
Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
[TBL] [Abstract][Full Text] [Related]
37. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
38. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants.
Reisser D; Olsson NO; Martin F
Int J Cancer; 1993 Feb; 53(4):651-6. PubMed ID: 8436439
[TBL] [Abstract][Full Text] [Related]
40. Analysis of factors associated with the tumorigenic potential of 12 tumor clones derived from a single rat colon adenocarcinoma.
Zennadi R; Garrigue L; Ringeard S; Ménoret A; Blanchardie P; Le Pendu J
Int J Cancer; 1992 Dec; 52(6):934-40. PubMed ID: 1459734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
